No Picture
Newsmakers

CLINIGENCE HOLDINGS AND NUTEX HEALTH (NASDAQ: NUTX) ANNOUNCE COMPLETION OF MERGER AND LISTING ON THE NASDAQ CAPITAL MARKET

FORT LAUDERDALE, Fla. and HOUSTON, April 4, 2022 /PRNewswire/ — Clinigence Holdings, Inc. (“Clinigence” or the “Company”) (OTC: NUTX), a primary care-centric, technology-enabled, risk-bearing population health management company, and Nutex Health Holdco LLC (“Nutex Holdco”), together with its affiliates […]

Newsmakers

DeepMarkit (OTC: MKTDF) Appoints Oscar Mendoza and Geoffrey Fielding to Advisory Board

The Formation of the Special Advisory Board Strengthens and Guides the Company’s Mission to Democratize Access To Global Carbon Credit Markets CALGARY, AB, March 29, 2022  – DeepMarkit Corp., (“DeepMarkit” or the “Company”) (TSXV: MKT) (OTC: MKTDF) (FRA: DEP), a […]

Healthcare

Pharmadrug (OTC: LMLLF)Advances PD-001, Its Patented, Improved Version of Cepharanthine for Oncology and Infectious Disease

Committed to the ‘pipeline-in-a-pill’ approach with PD-001 for certain cancers and COVID-19 Advances cGMP manufacturing of clinical drug supply with Southwest Research Institute Receives final positive data for recently conducted prostate cancer model and evaluates […]

Spotlight Stocks

Moderna, Inc. (NASDAQ: MRNA) CEO Stephane Bancel: ”Unique Opportunity to Transform Traditional Vaccine Market”

Moderna, Inc. (NASDAQ: MRNA) Vaccines Day Conference CEO Stephane Bancel Comments CEO Stephane Bancel: “…If you just look at the impact of vaccination on health over the last, let’s say, 20 years, it has been […]

CEO Interview

NEXT SUPER STOCK: PharmaDrug (OTC: LMLLF) (CSE: PHRX) Advancing BioPharm Assets w Billion Dollar Markets

NEXT SUPER STOCK: PharmaDrug (OTC: LMLLF) (CSE: PHRX) CEO Daniel Cohen shares update on LMLLF’s Advancing BioPharma pipeline assets addressing billion dollar markets opportunities in cancer, and glaucoma therapeutics. March 30, 2022 livestream     […]

Healthcare

Biodesix (NASDAQ: BDSX) Announces Publication Further Validating the Use of Liquid Biopsies and NGS Techniques to Provide Clinical Information for Patients With Cancer

Additionally, data associated with the GeneStrat® ddPCR™ and Genestrat NGS™ blood tests will be presented at the American Association for Cancer Research (AACR) BOULDER, Colo., March 29, 2022–Biodesix, Inc. (NASDAQ: BDSX), a leading data-driven diagnostic solutions company with […]

CEO Interview

NEXT SUPER STOCK: Nova Mentis Life Sciences (OTC: NMLSF) Billions Opportunity w/ autism psilocybin

NEXT SUPER STOCK: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) CMO Marvin Hausman, M.D.: “Nova’s Psilocybin-based Therapeutics Showing Vast Potential for Autism and Other Neuroinflammatory Disorders” Update on  4/8/2022 livestream discussing clinical trial application […]

Consumer

Oragin Foods (OTC: OGGFF) Appoints Food and Beverage Industry Executive Matthew Merson to Advisory Board to Support U.S. Expansion

Mr. Merson has held executive leadership positions at some of the most recognized food and beverage brands including Danone, Coca-Cola, Glaceau, Boxed Water, ZICO, and currently serves as VP for the U.S. plant-based brand SIMULATE. […]

Healthcare

Nova Mentis (OTC: NMLSF) Begins Enrollment in North American Autism Study

VANCOUVER, BC, March 23, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is proud to announce […]

Healthcare

Nova Mentis (OTC: NMLSF) Study Confirms Oral Microdose Psilocybin Treatment of Autism

VANCOUVER, BC, Feb. 16, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is pleased to announce […]